These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8633842)

  • 61. Deterioration in renal function with enalapril but not losartan in a patient with renal artery stenosis in a solitary kidney.
    Missouris CG; Ward DE; Eastwood JB; MacGregor GA
    Heart; 1997 Apr; 77(4):391-2. PubMed ID: 9155634
    [No Abstract]   [Full Text] [Related]  

  • 62. Comparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan in mild-to-moderate hypertension. Irbesartan/Losartan Study Investigators.
    Kassler-Taub K; Littlejohn T; Elliott W; Ruddy T; Adler E
    Am J Hypertens; 1998 Apr; 11(4 Pt 1):445-53. PubMed ID: 9607383
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Efficacy and tolerability of fimasartan, a new angiotensin receptor blocker, compared with losartan (50/100 mg): a 12-week, phase III, multicenter, prospective, randomized, double-blind, parallel-group, dose escalation clinical trial with an optional 12-week extension phase in adult Korean patients with mild-to-moderate hypertension.
    Lee SE; Kim YJ; Lee HY; Yang HM; Park CG; Kim JJ; Kim SK; Rhee MY; Oh BH;
    Clin Ther; 2012 Mar; 34(3):552-568, 568.e1-9. PubMed ID: 22381711
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Microalbuminuria in patients with hypertension and cardiovascular comorbidity, REAL observational study of treatment with Irbesartan/HCTZ].
    Tschöpe C; Tschöpe R; Unger T
    MMW Fortschr Med; 2006 Jun; 148(25):48. PubMed ID: 16859162
    [No Abstract]   [Full Text] [Related]  

  • 65. Trumping the ACE.
    Vane J
    Lancet; 1995 Sep; 346(8979):916. PubMed ID: 7564719
    [No Abstract]   [Full Text] [Related]  

  • 66. A placebo-controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8 mg, and losartan, 50 mg, as monotherapy in patients with essential hypertension, using 36-h ambulatory blood pressure monitoring.
    Baguet JP; Nisse-Durgeat S; Mouret S; Asmar R; Mallion JM
    Int J Clin Pract; 2006 Apr; 60(4):391-8. PubMed ID: 16620350
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Failure of losartan to control blood pressure in scleroderma renal crisis.
    Caskey FJ; Thacker EJ; Johnston PA; Barnes JN
    Lancet; 1997 Mar; 349(9052):620. PubMed ID: 9057740
    [No Abstract]   [Full Text] [Related]  

  • 68. Treatment of posttransplant erythrocytosis with losartan.
    Ducloux D; Fournier V; Bresson-Vautrin C; Chalopin JM
    Transplant Proc; 1997 Aug; 29(5):2407-8. PubMed ID: 9270784
    [No Abstract]   [Full Text] [Related]  

  • 69. [Milestone studies provide evidence: sartans have a nephroprotective effect. Evidence is clear].
    Bold KO
    MMW Fortschr Med; 2001 May; 143(22):12-3. PubMed ID: 11460392
    [No Abstract]   [Full Text] [Related]  

  • 70. Olmesartan-associated enteropathy. A rare but easily treatable entity.
    Karakonstantis S; Tzagkarakis E; Giannikaki E; Paspatis G
    Acta Gastroenterol Belg; 2017; 80(4):541-543. PubMed ID: 29560654
    [No Abstract]   [Full Text] [Related]  

  • 71. Acute kidney injury secondary to diarrhea caused by "sprue-like" enteropathy associated with olmesartan.
    Roca-Argente L; Diaz-Jaime FC; López-Romero LC; Manzur-Aguilar Y; Moll-Guillem JL; Del Val-Antoñana A; Hernandez-Jaras J
    Nefrologia; 2017; 37(5):548-550. PubMed ID: 28027786
    [No Abstract]   [Full Text] [Related]  

  • 72. [Losartan, an angiotensin II receptor blocker: a new trend in cardiovascular chemotherapy].
    Krasnikova TL
    Klin Med (Mosk); 1996; 74(3):17-21. PubMed ID: 8926692
    [No Abstract]   [Full Text] [Related]  

  • 73. [Cross reactivity between ACE inhibitors and angiotensin receptor blockers].
    Rosenborg S
    Lakartidningen; 2010 Feb 17-23; 107(7):444. PubMed ID: 20384078
    [No Abstract]   [Full Text] [Related]  

  • 74. [Sprue-like enteropathy in the elderly treated with olmesartan].
    Calvo Beguería E; Martinez Huguet C; Gonzalez García MP; Omiste SanVicente T
    Rev Esp Geriatr Gerontol; 2017; 52(4):223-224. PubMed ID: 28277303
    [No Abstract]   [Full Text] [Related]  

  • 75. Irbesartan-associated persistent edema of the eyelids, face, and neck.
    Cohen PR
    J Drugs Dermatol; 2002 Dec; 1(3):329-30. PubMed ID: 12851994
    [TBL] [Abstract][Full Text] [Related]  

  • 76. End-stage renal failure after irbesartan prescription in a diabetic patient with previously stable chronic renal insufficiency.
    Descombes E; Fellay G
    Ren Fail; 2000 Nov; 22(6):815-21. PubMed ID: 11104169
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Olmesartan-associated sprue-like enteropathy.
    Stanich PP; Yearsley M; Meyer MM
    J Clin Gastroenterol; 2013; 47(10):894-5. PubMed ID: 23751857
    [No Abstract]   [Full Text] [Related]  

  • 78. Losartan protects the rat kidney from ischemic injury.
    Heller J; Kramer HJ; Cervenka L; Hellerová S
    Kidney Int Suppl; 1996 Jun; 55():S113-4. PubMed ID: 8743528
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cardiology patient page. Angiotensin receptor blockers.
    Terra SG
    Circulation; 2003 Jun; 107(24):e215-6. PubMed ID: 12821593
    [No Abstract]   [Full Text] [Related]  

  • 80. Autoimmune-like chronic hepatitis induced by olmesartan.
    Barge S; Ziol M; Nault JC
    Hepatology; 2017 Dec; 66(6):2086-2088. PubMed ID: 28437842
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.